Market
Highlights
According
to MRFR analysis, Antiemetics Market Size is expected to register a
CAGR of 6.6% during the forecast period of 2019 to 2025 and account
for USD 6.7 Billion in 2025.
The
Global Antiemetics Market Size is expected to grow at a steady pace. There are
numerous antiemetics agents available for the treatment of nausea and vomiting,
including; dopamine antagonists, anticholinergics, antihistamines, serotonin
antagonists, and others. The key players manufacturing these products include
GSK, Merck, and Pfizer Inc. As these players generate their maximum revenue
from the Americas for the market, the region accounted for significant share
across the globe.
The
market is expected to grow at a steady growth rate. The significant factors
influencing the growth of the market include increasing investment in the
pharmaceutical industry, increasing the number of postoperative procedures,
pregnancy-induced nausea, and acute gastroenteritis, further influencing the
growth of the market. Moreover, the rising demand for novel therapeutics and
the increasing prevalence of postoperative nausea and vomiting (PONV) is
responsible for positive market growth.
Segmentation
The
Global Antiemetics Market Size has been segmented into agents, drug type,
application, and distribution channel.
By
agents, the market has been segmented into dopamine antagonists,
anticholinergics, antihistamines, serotonin antagonists, cannabinoids, and
others. Furthermore, dopamine antagonists is segmented into phenothiazines
(chlorpromazine, prochlorperazine), butyrophenones (droperidol, domperidone ),
and benzamides. Moreover, serotonin antagonists is further divided into
ondansetron, granisetron. The others segment includes dexamethasone and propofol.
Dopamine accounted for the largest market share majorly due to FDA approval for
the maximum number of application
By drug
type, the market is segmented into prescribed and OTC. Prescribed drugs
accounted for the large share by drugs type due to the high cost of the drugs
when compared to OTC and also are most prescribed by the professionals.
Based on
application, the market is segmented into chemotherapy, motion sickness,
stomach flu, pregnancy, postoperative surgery, and others. Postoperative surgery
accounted for the largest market share on the basis of attributing to an
increasing number of surgery procedures and mandatory postoperative procedures
for the same.
The
global Antiemetics Market Size, by distribution channel, has been a retail
pharmacy, hospital pharmacy, online. On the basis of distribution channel,
retail pharmacies accounted for the largest share due to the presence of a
large number of retail pharmacies across the globe.
Key Players
Some of the key players in the Global Antiemetics Market Size
are GSK (UK), Merck (US), Sanofi-Aventis (France), Pfizer Inc. (US), Mylan
(US), Eli Lilly and Company (US), Johnson & Johnson (US), Baxter
International (US), Dr. Reddy's Laboratories Inc. (India) and others.
Regional
Analysis
On a
regional basis, the Americas are anticipated to dominate the global Antiemetics
Market Size owing to the growing clinical research & development budgets by
both public and private organizations in the pharmaceutical industry,
increasing demand for novel therapeutics and the abundant presence of
significant manufacturer in the region. Additionally, rising postoperative
procedures is expected to influence the growth of the market. According to a
study, it is found that PONV occurs in nearly 30% of the general surgical
population and up to 70% to 80% of high-risk surgical patients. Europe is
expected to account for the second-largest market in the global Antiemetics
Market Size owing to well-developed research infrastructure, increasing
healthcare awareness in the region, and high expenditure in pharmaceutical
research.
Moreover,
rising healthcare expenditure is boosting the market in this region.
Asia-Pacific is expected to be the fastest-growing region due to the growing
interest of major key players in entering emerging markets, increasing
development in the pharmaceutical industry in this region. Moreover, increasing
the adoption of chemotherapy for the treatment of cancer expected to influence
the growth of the market. The Middle East & Africa is expected to account
for the least share of the global Antiemetics Market Size. Moreover, the
significant market share of the region is expected to be held by the Middle
East region owing to the increasing investment by major manufacturers and
changing healthcare reforms.
No comments:
Post a Comment